Request Deal Involvement

Sofinnova Investments and Novo Holdings led a $165m Series A round in Expedition Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

KKH Advisors

pr advisors

KKH Advisors

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

or

Principals

SANOFI VENTURES

bidder

SANOFI VENTURES

SOFINNOVA INVESTMENTS

bidder

SOFINNOVA INVESTMENTS

NOVO HOLDINGS AS

bidder

NOVO HOLDINGS AS

EXPEDITION THERAPEUTICS

target

EXPEDITION THERAPEUTICS

LOGOS CAPITAL

bidder

LOGOS CAPITAL

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

BVF PARTNERS

bidder

BVF PARTNERS

KKR & CO

bidder

KKR & CO

ADAGE CAPITAL MANAGEMENT

bidder

ADAGE CAPITAL MANAGEMENT

BALYASNY ASSET MANAGEMENT LP

bidder

BALYASNY ASSET MANAGEMENT LP

VENROCK HEALTHCARE CAPITAL PARTNERS

bidder

VENROCK HEALTHCARE CAPITAL PARTNERS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Sofinnova Investments and Novo Holdings led a $165m Series A round in Expedition Therapeutics.